Baker Bros. Advisors’s Arcturus Therapeutics ARCT Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q1 | – | Sell |
-151,329
| Closed | -$2.57M | – | 89 |
|
|
2024
Q4 | $2.57M | Hold |
151,329
| – | – | 0.03% | 82 |
|
|
2024
Q3 | $3.51M | Hold |
151,329
| – | – | 0.04% | 74 |
|
|
2024
Q2 | $3.68M | Buy |
+151,329
| New | +$3.68M | 0.05% | 74 |
|
|
2017
Q1 | – | Sell |
-333,766
| Closed | -$4.91M | – | 123 |
|
|
2016
Q4 | $4.91M | Hold |
333,766
| – | – | 0.05% | 64 |
|
|
2016
Q3 | $5.77M | Hold |
333,766
| – | – | 0.05% | 66 |
|
|
2016
Q2 | $10.5M | Hold |
333,766
| – | – | 0.11% | 52 |
|
|
2016
Q1 | $8.86M | Hold |
333,766
| – | – | 0.09% | 60 |
|
|
2015
Q4 | $14.7M | Buy |
333,766
+99,499
| +42% | +$4.37M | 0.12% | 54 |
|
|
2015
Q3 | $9.91M | Sell |
234,267
-21,429
| -8% | -$906K | 0.09% | 62 |
|
|
2015
Q2 | $11.7M | Hold |
255,696
| – | – | 0.1% | 59 |
|
|
2015
Q1 | $10.1M | Buy |
255,696
+214,286
| +517% | +$8.45M | 0.08% | 56 |
|
|
2014
Q4 | $1.08M | Buy |
+41,410
| New | +$1.08M | 0.01% | 114 |
|